Patents by Inventor Gilles Cloutier

Gilles Cloutier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHALATION FORMULATIONS OF TREPROSTINIL
    Publication number: 20150164834
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Applicant: United Therapeutics Corporation
    Inventors: Gilles Cloutier, James Crow, Michael Wade, Richard E. Parker, James E. Loyd
  • Inhalation formulations of treprostinil
    Publication number: 20090124697
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 19, 2008
    Publication date: May 14, 2009
    Inventors: Gilles Cloutier, James Crow, Michael Wade, Richard E. Parker, James E. Loyd
  • Method for delivering benzindene prostaglandins by inhalation
    Patent number: 6756033
    Abstract: A method of delivering benzindene prostaglandins to a patient by inhalation is discussed. A benzindene prostaglandin known as UT-15 has unexpectedly superior results when administered by inhalation compared to parenterally administered UT-15 in sheep with induced pulmonary hypertension.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: June 29, 2004
    Assignee: United Therapeutics Corporation
    Inventors: Gilles Cloutier, James Crow, Michael Wade, Richard E. Parker, James E. Loyd
  • Method for delivering benzidine prostaglandins by inhalation
    Publication number: 20030053958
    Abstract: A method of delivering benzindene prostaglandins to a patient by inhalation is discussed. A benzindene prostaglandin known as UT-15 has unexpectedly superior results when administered by inhalation compared to parenterally administered UT-15 in sheep with induced pulmonary hypertension.
    Type: Application
    Filed: August 6, 2002
    Publication date: March 20, 2003
    Applicant: United Therapeutics Corporation
    Inventors: Gilles Cloutier, James Crow, Michael Wade, Richard E. Parker, James E. Loyd
  • Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
    Patent number: 6521212
    Abstract: A method of delivering benzindene prostaglandins to a patient by inhalation is discussed. A benzindene prostaglandin known as UT-15 has unexpectedly superior results when administered by inhalation compared to parenterally administered UT-15 in sheep with induced pulmonary hypertension.
    Type: Grant
    Filed: March 15, 2000
    Date of Patent: February 18, 2003
    Assignee: United Therapeutics Corporation
    Inventors: Gilles Cloutier, James Crow, Michael Wade, Richard E. Parker, James E. Loyd
  • Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease
    Patent number: 6054486
    Abstract: An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene) -13,14-dihydro-prostaglandin F.sub.1.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: April 25, 2000
    Assignee: United Technology Corporation
    Inventors: James W. Crow, Shelmer D. Blackburn, Jr., Robert Roscigno, Michael Wade, Gilles Cloutier, Martine Rothblatt
  • Plug-in air freshener
    Patent number: D418214
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: December 28, 1999
    Assignee: Hubmar Inc.
    Inventor: Gilles Cloutier